GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCA2 | 32 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.0021 | 17510412
|
ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.0604 | 17510412
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.1739 | 17510412
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | Cisplatin | FACs for CSC marker followed by qRT-PCR | NA | 0.2 | 0.7582 | 33550205
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | Cisplatin | FACs for CSC marker followed by qRT-PCR | NA | 0.2 | 0.5695 | 33550205
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | Cisplatin | ALDEFLUOR assay followed by CFA | NA | 0.12 | 0.684 | 33550205
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | SK-MES-1 | Cisplatin | FACs followed by CFA | NA | 0.12 | 1 | 33550205
|